
Bayer gets sought-after heart failure use for Kerendia
Bayer's Kerendia has won FDA approval for a new heart failure indication thought to be pivotal for the product's blockbuster sales prospects.
Newsletters and Deep Dive digital magazine
Bayer's Kerendia has won FDA approval for a new heart failure indication thought to be pivotal for the product's blockbuster sales prospects.
Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
EU President Ursula von der Leyen has survived a no-confidence vote over text messages she sent to Pfizer's CEO about COVID-19 vaccine procurement.
Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.
Editor's Picks
Newsletters and Deep Dive
digital magazine